2021 consultation responses

The Royal Pharmaceutical Society responded to the following consultations in 2021.

January 2021

Consultation on Future Arrangements for Early Medical Abortion at Home | Scottish Government

Workplace health: long-term sickness absence and capability to work | NICE

Your views: building a strong, integrated care system across England | NHS England

Strategy Consultation | CQC

Community Diagnostics | Welsh Government

Draft design principles – clinical and care professional leadership in Integrated Care Systems (ICSs) | NHS Confederation

Inquiry into the Covid-19 outbreak on health and social care in Wales: Post-Covid Syndrome | Welsh Parliament Health, Social Care and Sport Committee

White Paper on health and social care | House of Commons Health and Social Care Committee Department

NHS Provider Selection regime: Consultation on proposals | NHS

April 2021

Draft Environmental Protection (single use plastic products) regulations | Scottish Government

Reviewing our process for health technology evaluation | NICE

Guideline on weight management | NICE

Call for Evidence – Barriers to research for controlled drugs (excluding synthetic cannabinoids) | ACMD

May 2021

Private coronavirus (COVID-19) testing validation | DHSC

Type 1 diabetes in adults: diagnosis and management (update) | NICE

Indicators for antidepressant prescribing and dementia | NICE

Consultation on a Patient Safety Commissioner Role for Scotland | Scottish Government

National Healthcare Uniform Workforce Consultation | NHS Supply Chain

June 2021

Consultation on how we set fees for pharmacy professionals | GPhC

Nuromol Dual Action Pain Relief 200mg/500mg tablets (ibuprofen/paracetamol) consultation | MHRA

Regulating healthcare professionals, protecting the public | DHSC

Women's Health Strategy: Call for Evidence | DHSC

Review of Tramadol Resources | AWTTC

July 2021

Consultation on the equality, diversity and inclusion strategy | GPhC

Race Equality Action Plan: An Anti-racist Wales | Welsh Gov

NHSX Data Strategy Survey | NHSX